Below is a video of Dr. Christina Sanchez, a molecular biologist at Compultense University in Madrid, Spain, clearly explaining how THC (the main psychoactive constitute of the cannabis plant) completely kills cancer cells.

   

CBD Medical Studies

Below is a partial list of clinical studies which show positive results pointing to evidence of CBD’s anti-cancer properties.

CBD brain cancer studies:

CBD breast cancer studies:

CBD lung cancer studies:

CBD prostate cancer studies:

CBD blood cancer studies:

CBD oral cancer studies:

CBD liver cancer studies:

CBD pancreatic cancer studies:

Studies have shown CBD to reduce epileptic seizures, and may also reduce schizophrenic symptoms due to its apparent ability to stabilize disrupted or disabled NMDA receptor pathways in the brain, which are shared and sometimes contested by norepinephrine and GABA.

Studies have shown cannabidiol decreases activity of the limbic system and decreases social isolation induced by THC in rats.

Note: CBD has not been evaluated by the Food and Drug Administration (FDA). CBD INC. makes no claims as to the effectiveness of CBD in treating any specific ailments. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites.

CBD Legal status

Cannabidiol is not scheduled by the Convention on Psychotropic Substances. The sale of imported CBD is legal in all 50 US states. CBD has received orphan drug status in the United States, for treatment of Dravet syndrome which will allow it to be studied in clinical medical trials.

Cosmetics Applications

Cannabidiol has been listed in EU Cosmetics Ingredient Database with four functional claims:

  • Antioxident
  • Antiseborrhoeic
  • Skin Conditioning
  • Skin Protecting

Cannabidiol.svgCBD Technical Information

Chemistry

Cannabidiol is insoluble in water but soluble in organic solvents such as pentane. At room temperature, it is a colorless crystalline solid. In strongly basic media and the presence of air, it is oxidized to a quinone. The synthesis of cannabidiol has been accomplished by several research groups.

Biosynthesis

Cannabis produces CBD-carboxylic acid through the same metabolic pathway as THC, until the last step, where CBDA synthase performs catalysis instead of THCA synthase.

Isomerism

7 DOUBLE BOND ISOMERS AND THEIR 30 STEREOISOMERSCannabidiol numbering
FORMAL NUMBERING TERPENOID NUMBERING NUMBER OF STEREOISOMERS NATURAL OCCURRENCE CONVENTION ON PSYCHOTROPIC SUBSTANCES SCHEDULE STRUCTURE
SHORT NAME CHIRAL CENTERS FULL NAME SHORT NAME CHIRAL CENTERS
Δ5-cannabidiol 1 and 3 2-(6-isopropenyl-3-methyl-5-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol Δ4-cannabidiol 1 and 3 4 No unscheduled 2-(6-Isopropenyl-3-methyl-5-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol.png
Δ4-cannabidiol 1, 3 and 6 2-(6-isopropenyl-3-methyl-4-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol Δ5-cannabidiol 1, 3 and 4 8 No unscheduled 2-(6-Isopropenyl-3-methyl-4-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol.png
Δ3-cannabidiol 1 and 6 2-(6-isopropenyl-3-methyl-3-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol Δ6-cannabidiol 3 and 4 4  ? unscheduled 2-(6-Isopropenyl-3-methyl-3-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol.png
Δ3,7-cannabidiol 1 and 6 2-(6-isopropenyl-3-methylenecyclohex-1-yl)-5-pentyl-1,3-benzenediol Δ1,7-cannabidiol 3 and 4 4 No unscheduled 2-(6-Isopropenyl-3-methylenecyclohex-1-yl)-5-pentyl-1,3-benzenediol.png
Δ2-cannabidiol 1 and 6 2-(6-isopropenyl-3-methyl-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol Δ1-cannabidiol 3 and 4 4 Yes unscheduled 2-(6-Isopropenyl-3-methyl-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol.png
Δ1-cannabidiol 3 and 6 2-(6-isopropenyl-3-methyl-1-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol Δ2-cannabidiol 1 and 4 4 No unscheduled 2-(6-Isopropenyl-3-methyl-1-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol.png
Δ6-cannabidiol 3 2-(6-isopropenyl-3-methyl-6-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol Δ3-cannabidiol 1 2 No unscheduled 2-(6-Isopropenyl-3-methyl-6-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol.pngBased on: Nagaraja, Kodihalli Nanjappa,Synthesis of delta-3-cannabidiol and the derived rigid analogs, Arizona University 1987.
 
CBD-3D-balls.pngSYSTEMATIC (IUPAC) NAME
2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
CLINICAL DATA
TRADE NAMES Epidiolex
AHFS/DRUGS.COM International Drug Names
LEGAL STATUS
  • CA: Schedule II
  • US: Unscheduled
PHARMACOKINETIC DATA
BIOAVAILABILITY 13-19% (oral), 11-45% (mean 31%; inhaled)
BIOLOGICAL HALF-LIFE 9 h
IDENTIFIERS
CAS NUMBER 13956-29-1 Yes
ATC CODE None
PUBCHEM CID 644019
IUPHAR/BPS 4150
CHEMSPIDER 24593618 Yes
UNII 19GBJ60SN5 Yes
CHEMICAL DATA
FORMULA C21H30O2
MOLAR MASS 314.4636
PHYSICAL DATA
MELTING POINT 66 °C (151 °F)
BOILING POINT 180 °C (356 °F)
(range: 160–180 °C)